Hemodynamic effects of potentially useful antineoplastic agents

Area of Science:

• Biochemistry
• Pharmacology
• Cardiovascular Physiology

Background:

• Adenosine (Ado) and its analogues exhibit diverse hemodynamic effects, including vasodilation and cardiac alterations.
• Purine and pyrimidine analogues are investigated for antineoplastic potential.
• Preclinical assessment of novel antineoplastic agents requires evaluation of their cardiovascular impact.

Purpose of the Study:

• To assess the hemodynamic effects of various adenosine analogues and related antineoplastic agents.
• To evaluate electrocardiogram and blood pressure changes induced by these agents in a preclinical model.
• To identify potential adverse cardiovascular reactions associated with these drug candidates.

Main Methods:

• Utilized intact anesthetized Sprague-Dawley rats for hemodynamic evaluation.
• Administered a series of purine and pyrimidine analogues, including arabinosyladenine, its derivatives, formycins, and others.
• Investigated adenosine analogues susceptible to adenosine deaminase (ADA) after ADA inhibition with 2'-deoxycoformycin.

Main Results:

• Tested antineoplastic agents demonstrated significant hemodynamic effects.
• Observed alterations in electrocardiogram and blood pressure were drug-dependent.
• Deamination susceptibility influenced the hemodynamic profile of certain adenosine analogues.

Conclusions:

• Adenosine analogues investigated as antineoplastic agents possess notable hemodynamic activities.
• Clinicians should be aware of potential adverse cardiovascular reactions when administering these drugs.
• Preclinical hemodynamic profiling is crucial for the safe development of novel antineoplastic therapies.